Built with Claude: Life Sciences hackathon
Research track · 2026

A DNA sequence model reads a disease regulatory element, base by base.

I asked AlphaGenome, a pretrained sequence model, to predict the effect of every single-base change in a panel of disease regulatory elements, from DNA alone. It reproduces the wet-lab saturation-mutagenesis maps, and, shown no clinical information, places a canonical cancer driver at the very top of its ranking. As a check I also trained my own model on AWS with the CLI, orchestrated by Claude Code, and the pretrained model holds its own with no training at all.

39,170
single-base substitutions predicted, zero-shot
+0.53
Spearman on the TERT promoter, no fitted parameters
3 / 3
clinical positions in the model's top decile
19 / 21
disease loci recovered above chance

The result. Blind to every annotation, the model's single highest-impact predicted variant is chr5:1295135 G>A, the pathogenic TERT C250T promoter mutation, a recurrent driver in melanoma and glioblastoma. The neighbouring C228T hotspot appears in the same ranking. Both are recovered from DNA alone.

A trained comparator. To calibrate the zero-shot result, I also trained a supervised gradient-boosted model on the measured effects, run as a managed AWS SageMaker job from the command line. Head to head, the pretrained model matches it across the atlas by the median, pulls ahead on the TERT promoter, and transfers to a held-out locus without ever fitting a measured value, where the trained model collapses.

About me

William Guesdon

I'm William Guesdon, PhD, a data scientist and bioinformatician. I use data science and machine learning to turn multi-omics data into results teams can trust, with an emphasis on reproducibility.